Cognetti Daniel J
Arthroscopy. 2025 Jan;41(1):128-129. doi: 10.1016/j.arthro.2024.05.016. Epub 2024 Jun 1.
In 2021, the Centers for Medicare & Medicaid Services introduced hospital price transparency regulations, but many hospitals are still not entirely compliant, and the available data are unwieldy and opaque. The currently available data offer little insight for patients seeking to understand their actual out-of-pocket costs. Fortunately, as of January 1, 2024, the Transparency in Coverage rule mandates that insurers provide real-time cost estimator tools for out-of-pocket expenses for all medical items and services. This is crucial because price-based competition depends on patient- and insurance-specific factors, including insurance coverage (or lack thereof), access to care, and accurate estimates of out-of-pocket cost. Insurance coverage complicates hospital transparency efforts due to marked differences in billed charges and insurance payouts. If patients could input their insurance details and the service or surgery charge into a price estimator, they could receive realistic estimates across different hospitals. This could be an equitable goal. However, even if a patient can determine out-of-pocket costs, there is little actual competition when coverage only applies to hospitals within a parent network. Price transparency has the potential to substantially benefit patients, but current hospital-centric data are insufficient. Patient-centric price transparency is required; sadly, it seems that hospitals will not provide these data without tighter regulation.